Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-11
2006-07-11
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S332000
Reexamination Certificate
active
07074802
ABSTRACT:
The invention thus provides the compounds of formula (I)and pharmaceutically acceptable salts thereof, in which:R1and R2are independently selected from the group consisting of H, C1-6alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl and C4-12bridged cycloalkyl;R3is selected from the group consisting of C1-6alkyl, NH2and R5CONH;R4is selected from the group consisting of CH2F, CHF2, CF3CH2, CF3CHF and CF3CF2; andR5is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl.Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.
REFERENCES:
patent: 3149109 (1964-09-01), Neustaedter et al.
patent: 3592895 (1971-07-01), Hepworth et al.
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5760068 (1998-06-01), Talley et al.
patent: 5972986 (1999-10-01), Seibert et al.
patent: 6020343 (2000-02-01), Belley et al.
patent: 6153619 (2000-11-01), Wood et al.
patent: 6306866 (2001-10-01), Wood et al.
patent: 6313072 (2001-11-01), Scheiblich et al.
patent: 6780869 (2004-08-01), Green et al.
patent: 6780870 (2004-08-01), Naylor et al.
patent: 2003/0013717 (2003-01-01), Mangel et al.
patent: 19909541 (1999-03-01), None
patent: 9241161 (1997-09-01), None
patent: WO 96/07641 (1996-03-01), None
patent: WO 96/24585 (1996-08-01), None
patent: WO 96/41625 (1996-12-01), None
patent: WO 96/41645 (1996-12-01), None
patent: WO/98/03484 (1998-01-01), None
patent: WO 98/16227 (1998-04-01), None
patent: WO/98/24782 (1998-06-01), None
patent: WO 99/01439 (1999-01-01), None
patent: WO/01/38311 (2001-05-01), None
patent: WO/01/58881 (2001-08-01), None
patent: WO/02/18374 (2002-03-01), None
patent: WO/02/096427 (2002-12-01), None
patent: WO/02/096885 (2002-12-01), None
patent: WO/02/096886 (2002-12-01), None
Simone, J.V., “Oncology: Introduction” Cecil Texbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Layzer, R.B., “Degenerative Diseases of the Nervous System” Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.
Damasio, A.R. “Alzheimer's Disease and Related Dementias” Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.
Freston, JW. “Rationalizing Cyclooxygenase (COX) Inhibition for Maximal Efficacy and Minimal Adverse Events & Discussion.” PubMed Abstract, Am J Med 107(6A):78S-88S, Discussion 89S), Dec. 1999.
Naesdal, J. et al. “Gastro-Duodenal Protection in an Era of Cyclo-Oxygenase-2-Selective Nonsteroidal Anti-inflammatory Drugs.” PubMed Abstract, Eur J Gastroenterol Hepatol, 13(12):1401-1406, Dec. 2001.
Douglas, R.G., Jr. Introduction to Viral Diseases: Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1739-1747, 1996.
Doughty, legal representative Jennifer
Hartley Charles David
Naylor Alan
Payne Jeremy John
Pegg Neil Anthony
Glaxo Group Limited
Rao Deepak
Young J. Scott
LandOfFree
Pyrimidine derivatives as selective inhibitors of cox-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives as selective inhibitors of cox-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives as selective inhibitors of cox-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3551641